PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 93 filers reported holding PMV PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 1.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,245 | -34.9% | 8,509 | -33.7% | 0.00% | – |
Q2 2023 | $80,310 | -46.9% | 12,829 | -59.5% | 0.00% | – |
Q1 2023 | $151,195 | -46.6% | 31,697 | -2.6% | 0.00% | – |
Q4 2022 | $283,002 | -26.1% | 32,529 | +1.1% | 0.00% | -100.0% |
Q3 2022 | $383,000 | -18.5% | 32,186 | -2.3% | 0.00% | 0.0% |
Q2 2022 | $470,000 | +8.3% | 32,960 | +58.1% | 0.00% | 0.0% |
Q1 2022 | $434,000 | -20.8% | 20,847 | -12.1% | 0.00% | 0.0% |
Q4 2021 | $548,000 | -21.3% | 23,727 | +1.6% | 0.00% | 0.0% |
Q3 2021 | $696,000 | -43.6% | 23,362 | -35.4% | 0.00% | -50.0% |
Q2 2021 | $1,235,000 | +81.6% | 36,166 | +75.0% | 0.00% | +100.0% |
Q1 2021 | $680,000 | -46.5% | 20,662 | 0.0% | 0.00% | -50.0% |
Q4 2020 | $1,271,000 | – | 20,662 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INTERWEST VENTURE MANAGEMENT CO | 3,234,911 | $74,726,000 | 44.17% |
Euclidean Capital LLC | 2,336,909 | $53,983,000 | 30.69% |
OUP Management Co., LLC | 989,232 | $22,851,000 | 10.30% |
Nextech Invest Ltd. | 1,385,807 | $32,012,000 | 8.43% |
Boxer Capital, LLC | 2,838,236 | $65,563,000 | 2.55% |
PERSONAL CFO SOLUTIONS, LLC | 550,342 | $12,713,000 | 2.38% |
Orbimed Advisors | 7,330,423 | $169,333,000 | 2.18% |
Asymmetry Capital Management, L.P. | 97,680 | $2,256,000 | 1.20% |
RTW INVESTMENTS, LP | 2,980,960 | $68,860,000 | 1.01% |
HighVista Strategies LLC | 39,777 | $919,000 | 0.73% |